More than 200 people participated in reading the manifesto of the World Day for Rare Diseases

Source:

Over 200 people participated in reading the manifesto of the World Day for Rare Diseases, organized by the Gene D'Totana and the Spanish Federation for Rare Diseases, held yesterday at the Plaza of the Constitution in Totana.

During this act, the actor of Red Eagle, Guillermo Campra, who also attended the joint dinner where prizes were awarded to the association, was asked to read the manifest.

In addition, delivered gifts to children and released doves.

Today, on World of Rare Diseases, is performed at the Faculty of Medicine a talk in conjunction with the exhibition "Rare diseases are full of life."

Also, on 3 March will present the Awards of the Spanish Federation in the Senate and Princess Letizia Ortiz will be responsible with the Minister of Health, Leire Pajin, which will honor individuals or organizations that carry out important work with the Association.

Thus, according to Carrión will distinguish the figure of Dr. Murcia, Encarna Guillén, who has led the association since its inception D'Genes.

See story:

http://www.murcia.com/region/fotos/2011/dia-mundial-enfermedades-raras/

noticia
More than 200 people participated in reading the manifesto of the World Day for Rare Diseases, Foto 1

Comment this news on Facebook

If you want to comment on this news to the administrators of Totana.net, fill out the form below:

Send notification Code: 2024425
The owner of the personal data, collected in this form, expressly authorizes Alamo Networks, S.L. to treat said data in a computerized way and to be able to incorporate it into your database. The user may exercise the rights of access, rectification, cancellation and opposition of their personal data, in the terms established by the LOPD, at the address set in C / Alamo 8, 30850, Totana (Murcia). For your convenience you can also exercise your rights by email at the address info@totana.net
This website uses cookies to facilitate and improve navigation. If you continue browsing, we consider that you accept its use. More information